Queen Elizabeth Hospital, Birmingham, B15 2TH, and *Department of Clinical Endocrinology, Women's Hospital, Birmingham, BU 4HL
(Received 19 January 1976)
Administration of the natural or synthetic decapeptide known as luteinizing hormone/follicle-stimulating hormone releasing hormone (LH-RH) causes prompt release of both luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The decapeptide has a short half-life of only a few minutes, so that its use as a therapeutic agent in the treatment of infertility is limited. Attempts have been made therefore to synthesize more potent and longer-acting analogues. Many of these have only weak activity in experimental animals, but some, notably those with modifications to structure at residues 5, 6 and 10, are more effective (Arimura, Vilchez-Martinez, Coy, Coy, Hirotsu & Schally, 1974; Kastin, Arimura, Gonzalez-Barcena, Coy, Clinton-Miller, Nishi, Lee, Duron-Huerta, Schalch & Schally, 1974a; Kastin, Schally, Gonzalez-Barcena, Coy, Clinton-Miller, Porias & Schalch, 1974b; Vilchez-Martinez, Coy, Arimura, Coy, Hirotsu & Schally, 1974; Zañartu,
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 0 | 0 | 0 |
| PDF Downloads | 2 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
